Recent biotech financings include nine-figure rounds for Windward Bio and Coultreon, with Vivacta, Kanvas, and Moleculent also raising funds.
NICE backs stomach cancer, PAH drugs for NHS use
AZ’s Imfinzi is the first NHS immunotherapy for a form of stomach cancer, while MSD’s Winrevair gets a green light for rare respiratory disease PAH.


